Nalaganje...
Acute Kidney Injury Associated with Linagliptin
Linagliptin is a dipeptidyl peptidase-IV (DPP-IV) inhibitor that is approved for the treatment of type 2 diabetes mellitus. About 5% of linagliptin is eliminated by the kidneys and no dose adjustment is recommended in kidney impairment. We report a first case of linagliptin-associated acute kidney i...
Shranjeno v:
| izdano v: | Case Rep Endocrinol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi Publishing Corporation
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4769737/ https://ncbi.nlm.nih.gov/pubmed/26981294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5695641 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|